From: Human papillomavirus and bladder cancer: literature review and meta-analysis
# | Study name | Risk ratio | CI lower limit | CI upper limit | Weight (%) |
---|---|---|---|---|---|
1 | Smetana Z., 1995, Israel | 2.05 | 1.66 | 2.54 | 4.08 |
2 | W. Zengjun, 1996, China | 1.68 | 1.26 | 2.24 | 3.21 |
3 | Chaomei T.W.X.Y.L., 1998, China | 1.54 | 0.98 | 2.42 | 1.96 |
4 | M.I. Tekin, 1999, Turkey | 1.01 | 0.87 | 1.18 | 4.98 |
5 | W. Dinghai, 1999, China | 1.89 | 1.32 | 2.70 | 2.55 |
6 | D. Fioriti, 2003, Italy | 1.02 | 0.92 | 1.13 | 5.63 |
7 | M.R. Barghi, 2005, Iran | 1.48 | 1.19 | 1.83 | 4.05 |
8 | S. Youshya, 2005, UK | 0.98 | 0.92 | 1.05 | 5.97 |
9 | H. Badawi, 2008, Egypt | 1.64 | 1.06 | 2.53 | 2.00 |
10 | G. Eslami, 2008, Iran | 1.41 | 1.22 | 1.64 | 4.98 |
11 | K. Shigehara, 2009, Japan | 1.19 | 1.00 | 1.42 | 4.64 |
12 | T. Cai, 2010, Italy | 1.54 | 1.16 | 2.04 | 3.23 |
13 | K. Shigehara, 2010, Japan | 1.13 | 0.97 | 1.32 | 4.95 |
14 | A. Sorlozano, 2010, Spain | 1.00 | 0.90 | 1.12 | 5.52 |
15 | J. Xiao, 2011, China | 1.01 | 0.90 | 1.13 | 5.47 |
16 | T. Cai, 2011, Italy | 1.37 | 1.14 | 1.65 | 4.49 |
17 | G. I. Panagiotakis, 2013, Greece | 1.00 | 0.94 | 1.07 | 6.01 |
18 | N. Berrada, 2013, Morocco | 1.88 | 1.26 | 2.79 | 2.24 |
19 | S.H. Kim, 2014, Korea | 1.11 | 0.88 | 1.40 | 3.88 |
20 | S.C. Schmid, 2015, Germany | 0.93 | 0.76 | 1.15 | 4.17 |
21 | U.K. Mete, 2018, India | 0.96 | 0.84 | 1.10 | 5.21 |
22 | H. Badawi, 2018, Egypt | 1.50 | 1.26 | 1.79 | 4.61 |
23 | M. Yıldızhan, 2020, Turkey | 1.04 | 1.00 | 1.08 | 6.19 |
24 | Total | 1.21 | 1.09 | 1.34 | Â |